Ignite Creation Date:
2025-12-25 @ 3:43 AM
Ignite Modification Date:
2025-12-26 @ 2:29 AM
Study NCT ID:
NCT05368402
Status:
TERMINATED
Last Update Posted:
2025-02-03
First Post:
2022-05-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.
Sponsor:
Dompé Farmaceutici S.p.A
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-18
Completion Date Type:
ACTUAL
First Submit Date:
2022-05-05
First Submit QC Date:
None
Study First Post Date:
2022-05-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-11-04
Results First Submit QC Date:
None
Results First Post Date:
2025-02-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-28
Last Update Post Date:
2025-02-03
Last Update Post Date Type:
ACTUAL